Poland: Schoenherr advises sellers on MyBestPharm sale to Urgo Healthcare

Founded in 2021, MyBestPharm has quickly established itself as a digitally native leader in the health & wellness space, offering a sophisticated portfolio of high-quality products, including MyBestBeauty+, MyBestProtect and MyBestComplement. With Urgo's support, the company plans to scale its operations in Poland and across Europe, aiming to double its turnover by 2030.

Urgo Healthcare, part of the French family-owned Urgo Group, is a major European player in everyday healthcare, known for brands such as Urgo, Alvityl, Humer and Belloc. The acquisition further strengthens Urgo's position in Poland, one of its key strategic markets.

The Schoenherr team advising on the transaction consisted of Dawid Brudzisz (counsel), Tomasz Kwaśniewski (partner), Szymon Okoń (partner) and Olga Koncerewicz (associate).

The seller was also advised by Saski Partners (CFI Poland). The purchaser was advised by DLA Piper.